Faster Analysis Times for Pharma Raw Materials
October 19, 2012
Cobalt Light Systems is proud to announce RapID, a pioneering instrument for the identification of raw materials through the side of the unopened packaging. The pharmaceutical industry spends significant time and resource on verifying the identity of raw materials before they enter the manufacturing process. Accurate QC of these materials is essential and can be [...]
October 19, 2012
ALAMEDA, Calif.-- BioTime, Inc. (NYSE MKT: BTX) and its subsidiary, LifeMap Sciences, Inc., today announced the appointment of Louis E. Silverman to LifeMap Sciences’ board of directors. Mr. Silverman is an experienced health care executive with board level and operating experience in health care IT, pharmaceuticals, home health care, worker’s compensation managed care and revenue [...]
Clontech Laboratories, Inc. and Professor Sergey Lukyanov awarded the RUSNANOPRIZE 2012
October 19, 2012
MOUNTAIN VIEW, Calif., -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., is honored to receive the RUSNANOPRIZE 2012 together with Dr. Sergey Lukyanov, for the innovation "Fluorescent proteins of coral polyps: discovery and use in biotechnology". The RUSNANOPRIZE is a major international award for nanotechnology discoveries and innovations that was established by [...]
October 18, 2012
Madison, WI USA: Promega Corporation announced today that it has launched GoTaq® Probe PCR Master Mix, GoTaq Probe 1-Step RT-qPCR System, and GoTaq Probe 2-Step RT-qPCR System. These ready-to-use, 2x master mixes simplify the preparation of reactions for qPCR using hydrolysis probe detection, and are designed for sensitive sequence detection and quantification over a broad [...]
Genetic Technologies Executes Covenant Not To Sue And Release Agreement with One Lambda Inc.
October 18, 2012
In compliance with ASX Continuous Disclosure Rules, Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to report it has executed a Covenant Not To Sue And Release Agreement with One Lambda Inc. (“One Lambda”) of Canoga Park, California, USA. The precise commercial terms of the Agreement are covered by formal confidentiality provisions and cannot [...]
October 18, 2012
SOUTH EASTON, Mass., -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that two research groups have reported on the ability of the Company's Pressure Cycling Technology ("PCT") Platform to improve the detection of DNA in challenging forensic samples. The studies were presented by scientists from the Institute of Applied Genetics, Department [...]
The University of Manchester Moves into the 4th Dimension
October 18, 2012
PLEASANTON, CA, – Xradia, Inc., the world's leading manufacturer of 3D X-ray microscopes for the lab and synchrotron, announced today that The University of Manchester has purchased the VersaXRM-500 3D X-ray microscope with funding from The Engineering and Physical Science Research Council for use in its advanced imaging laboratory. Manchester selected the XRM to better [...]
GnuBIO Promotes Susie Truong Harborth to Key Role as Chief Financial Officer
October 18, 2012
CAMBRIDGE, Mass -- GnuBIO, Inc., a pioneer in desktop DNA sequencing, today announced that Susie Truong Harborth has been promoted to Chief Financial Officer. Ms. Harborth has been with GnuBIO, www.gnubio.com since the company’s inception and will continue to lead finance, human resources and operations of the company while taking on new responsibilities for company [...]
Complete Genomics Announces Court’s Favorable Ruling in Patent Litigation Against Illumina, Inc.
October 18, 2012
MOUNTAIN VIEW, Calif., -- Complete Genomics, Inc. (Nasdaq:GNOM) today announced that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California issued an Order granting Complete's Motion for Partial Summary Judgment of invalidity in the patent infringement lawsuit filed against Complete by Illumina, Inc. In that lawsuit, filed in [...]
October 18, 2012
BERLIN, --caprotec bioanalytics GmbH announced today a restructuring of its senior management and the appointment of Dr. Jonathan Turner as Managing Director and Chief Executive Officer. Dr. Turner joins caprotec as a highly regarded pharmaceutical executive and has held a number of senior management positions at global pharmaceutical companies, including Boehringer Ingelheim, AstraZeneca PLC and [...]
